Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Total 13F shares
-
161,240,868
-
Share change
-
+1,588,523
-
Total reported value
-
$16,892,503,727
-
Put/Call ratio
-
83%
-
Price per share
-
$104.76
-
Number of holders
-
381
-
Value change
-
+$165,350,997
-
Number of buys
-
181
-
Number of sells
-
188
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2015
As of 31 Dec 2015 BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) had 381 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 161,240,868 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, JENNISON ASSOCIATES LLC, JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, and BlackRock Institutional Trust Company, N.A..
This table shows 381 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.